4-Methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide

Catalog No. :
ACYLAW588
CAS No. :
331472-31-2
Molecular Formula :
C16H13N3O2S
Molecular Weight :
311.37

IUPAC Name:4-methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide

4-Methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide
IUPAC Name4-methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide
MDL No.MFCD05866519
Molecular FormulaC16H13N3O2S
Molecular Weight311.37
SMILESO=C(NC1=NC(C2=CC=CC=C2)=NS1)C3=CC=C(OC)C=C3
InChI KeyRGVXOHBJCGPTQH-UHFFFAOYSA-N
Synonym4-methoxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide | LUF-5417 | BDBM50097423 | STL203008 | AKOS000813206 | VU0618369-1 | EN300-1692894 | F3394-1093 | Z275024144 | 4-Methoxy-N-(3-phenyl-[1,2,4]thiadiazol-5-yl)-benzamide | 4-Methoxy-N-(3-phenyl-[1,2,4]th
CAS No.331472-31-2
PubChem CID667741

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYLAW588 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYLAW588 route product structure diagram
    ACYLAW588331472-31-2
Inquiry

2. ACYLAW588 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYLAW588 route product structure diagram
    ACYLAW588331472-31-2
Inquiry

Comments (0)